Reforgene Medicine
About:
Reforgene Medicine is a biomedical company that uses gene editing and genomic technology to develop drugs intended to cure genetic diseases.
Website: https://www.reforgene.com
Top Investors: BioVenture, Legend Star, BioTrack Capital, Alwin Capital, Sinovation Ventures
Description:
Reforgene Medicine is a biomedical company that uses gene editing and genomic technology to develop new drugs intended to cure genetic diseases.
Total Funding Amount:
$30.1M
Headquarters Location:
Guangzhou, Guangdong, China
Founded Date:
2019-01-01
Contact Email:
info(AT)reforgene.com
Founders:
Junbin Liang
Number of Employees:
11-50
Last Funding Date:
2023-04-28
IPO Status:
Private
Industries:
© 2025 bioDAO.ai